Consumer cost sharing and use of biopharmaceuticals for rheumatoid arthritis.

Conclusions: Consumer cost sharing reduces the use of physician-administered specialty drugs for rheumatoid arthritis. The higher use of patient self-administered specialty drugs suggests that the disincentives for use of physician-administered drugs were offset by an increased incentive to use self-administered drugs. PMID: 23844749 [PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/23844749?dopt=Abstract

Source: The American Journal of Managed Care - July 16, 2013 Category: Health Management Authors: Robinson JC Tags: Am J Manag Care Source Type: research